Our Team

Board of Directors

Andre G. Buret, PhD Calgary, Canada

Vice President Research, Antibe Therapeutics
Professor of Biological Sciences at the University of Calgary.

Roderick J. Flower, PhD London, UK

Deputy Director, Centre for Biochemical Pharmacology, William Harvey Research Institute;
Fellow of the Royal Society;
Past-President, British Pharmacological Society

Louis J. Ignarro, PhD Los Angeles, USA

1998 Nobel Prize for Medicine/Physiology;
Department of Molecular and Medical Pharmacology, UCLA

George Jackowski, PhD Toronto, Canada

Chairman, Phoenix Group of Companies, Toronto;
Chief Science Officer, Nanogen Inc.; Co-Founder, Spectral Diagnostics;

Dan Legault, LLB Toronto, Canada

President and CEO, Antibe Therapeutics

Daniel K. Podolsky, MD Cambridge, USA

Chief of Gastroenterology, Massachusetts General Hospital, Harvard Medical School;
Board of Director, Glaxo Smith Kline;
Past-President, American Gastroenterological Association (AGA)

John L. Wallace, PhD Calgary, Canada

Founder and Chief Science Officer, Antibe Therapeutics
Professor of Pharmacology & Therapeutics at the University of Calgary.